Ajinomoto Bio-Pharma Service
Ajinomoto Bio-Pharma Services is a global CDMO offering cutting-edge ADC Platform consists of site-specific chemical conjugation and linker. We have developed an innovative conjugation method based on Fc-affinity peptides that provides significant advantages for next generation ADCs; 1) straightforward and cost-effective CMC, requiring no genetic modification or enzymes; 2) enhanced therapeutic window compared with stochastic ADCs with flexible DAR options of 1, 2, 4 or higher; and 3) dual-payload approaches and other flexible drug designs.
